Tobias Financial Advisors’s AbbVie ABBV Stock Holding History

Tobias Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280K	Sell	1,114 -47	-4%	-$10.1K	0.04%	124
2026 Q1	$253K	Sell	1,161 -362	-24%	-$80.3K	0.04%	123
2025 Q4	$348K	Sell	1,523 -106	-7%	-$24.1K	0.05%	103
2025 Q3	$377K	Buy	+1,629	New	+$332K	0.06%	96
2020 Q1	–	Sell	-122	Closed	-$10K	–	60
2019 Q4	$10K	Buy	+122	New	+$10.1K	0.01%	184

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tobias Financial Advisors's ABBV Position: Q2 2026 in Review

Tobias Financial Advisors reduced its AbbVie (ABBV) stake by 4% in Q2 2026, selling an estimated $10.1K and leaving 1,114 shares worth $280K. The position accounts for 0.04% of the portfolio, ranked #124.

Tobias Financial Advisors first reported a position in ABBV in Q4 2019 and has held it in 5 quarters since. The position peaked at $377K in Q3 2025. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Tobias Financial Advisors held 1,114 shares of AbbVie worth $280K as of Q2 2026.
Tobias Financial Advisors sold 47 AbbVie shares in Q2 2026, an estimated $10.1K.
AbbVie made up 0.04% of Tobias Financial Advisors's portfolio in Q2 2026, its #124 holding.
Tobias Financial Advisors first reported a position in AbbVie in Q4 2019 and has held it in 5 quarters since.
Tobias Financial Advisors's AbbVie position peaked at $377K in Q3 2025.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tobias Financial Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.